GS
GILD icon

GAM Systematic’s Gilead Sciences GILD Stock Holding History

GAM Systematic’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$3.42M Buy
42,267
+19,808
+88% +$1.51M 0.49% 23
2017
Q2 		$1.59M Buy
+22,459
New +$1.49M 0.23% 162
2017
Q1 		– Sell
-5,385
Closed -$386K – 623
2016
Q4 		$386K Buy
5,385
+360
+7% +$26.8K 0.09% 381
2016
Q3 		$398K Sell
5,025
-8,776
-64% -$713K 0.08% 414
2016
Q2 		$1.15M Sell
13,801
-4,220
-23% -$375K 0.28% 108
2016
Q1 		$1.66M Buy
18,021
+4,283
+31% +$386K 0.44% 24
2015
Q4 		$1.39M Sell
13,738
-2,193
-14% -$228K 0.4% 33
2015
Q3 		$1.56M Sell
15,931
-23,876
-60% -$2.65M 0.36% 51
2015
Q2 		$4.66M Buy
39,807
+38,711
+3,532% +$4.23M 0.59% 34
2015
Q1 		$108K Buy
+1,096
New +$111K 0.01% 355

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GAM Systematic's GILD Position: Q3 2017 in Review

GAM Systematic increased its Gilead Sciences (GILD) stake by 88% in Q3 2017, buying an estimated $1.51M and bringing the position to 42,267 shares worth $3.42M. The position accounts for 0.49% of the portfolio, ranked #23.

GAM Systematic first reported a position in GILD in Q1 2015 and has held it in 10 quarters since. The position peaked at $4.66M in Q2 2015. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • GAM Systematic held 42,267 shares of Gilead Sciences worth $3.42M as of Q3 2017.
  • GAM Systematic bought 19,808 Gilead Sciences shares in Q3 2017, an estimated $1.51M.
  • Gilead Sciences made up 0.49% of GAM Systematic's portfolio in Q3 2017, its #23 holding.
  • GAM Systematic first reported a position in Gilead Sciences in Q1 2015 and has held it in 10 quarters since.
  • GAM Systematic's Gilead Sciences position peaked at $4.66M in Q2 2015.
  • 1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.